OBJECTIVE: To determine the aetiology of genital ulcers and discharges in rural south western Uganda and to assess response to syndromic treatment. METHOD: A longitudinal, prospective study using laboratory testing and questionnaires to evaluate 561 adult men and women presenting with clinically verified genital ulcers, urethral, or vaginal discharge at a general outpatient clinic and two health centres between December 1999 and July 2001. RESULTS: One third of patients had genital ulcers and two thirds discharges. There was good response to treatment in 461/508 patients (90.7%). Herpes simplex virus type 2 was found in 95/217 (43.8%) genital ulcers. In 24.1% of ulcer cases there was also a genital discharge. HIV seropositivity was high in ulcer cases (63.2%), with significantly more HSV2 and secondary bacterial infection than in seronegative cases. Neisseria gonorrhoeae was found in 135/204 (66.2%) male genital discharges. Female genital discharges were mostly associated with bacterial vaginosis (36.1%), Trichomonas vaginalis (18.9%), and candidiasis (18.6%). CONCLUSIONS: The aetiological pattern of STI syndromes reported will help inform revision of national STI guidelines. The importance of herpes simplex virus type 2, the variation in causes of genital ulcers according to HIV serostatus, the high frequency of multiple infections and secondary bacterial contamination of genital ulcers are notable. These results help explain the lack of effect of an STI intervention on HIV incidence in a recent trial in this area.
OBJECTIVE: To determine the aetiology of genital ulcers and discharges in rural south western Uganda and to assess response to syndromic treatment. METHOD: A longitudinal, prospective study using laboratory testing and questionnaires to evaluate 561 adult men and women presenting with clinically verified genital ulcers, urethral, or vaginal discharge at a general outpatient clinic and two health centres between December 1999 and July 2001. RESULTS: One third of patients had genital ulcers and two thirds discharges. There was good response to treatment in 461/508 patients (90.7%). Herpes simplex virus type 2 was found in 95/217 (43.8%) genital ulcers. In 24.1% of ulcer cases there was also a genital discharge. HIV seropositivity was high in ulcer cases (63.2%), with significantly more HSV2 and secondary bacterial infection than in seronegative cases. Neisseria gonorrhoeae was found in 135/204 (66.2%) male genital discharges. Female genital discharges were mostly associated with bacterial vaginosis (36.1%), Trichomonas vaginalis (18.9%), and candidiasis (18.6%). CONCLUSIONS: The aetiological pattern of STI syndromes reported will help inform revision of national STI guidelines. The importance of herpes simplex virus type 2, the variation in causes of genital ulcers according to HIV serostatus, the high frequency of multiple infections and secondary bacterial contamination of genital ulcers are notable. These results help explain the lack of effect of an STI intervention on HIV incidence in a recent trial in this area.
Authors: Eline L Korenromp; Roel Bakker; Sake J De Vlas; N Jamie Robinson; Richard Hayes; J Dik F Habbema Journal: Sex Transm Dis Date: 2002-04 Impact factor: 2.830
Authors: I M Malonza; M W Tyndall; J O Ndinya-Achola; I Maclean; S Omar; K S MacDonald; J Perriens; K Orle; F A Plummer; A R Ronald; S Moses Journal: J Infect Dis Date: 1999-12 Impact factor: 5.226
Authors: K Fonck; N Kidula; W Jaoko; B Estambale; P Claeys; J Ndinya-Achola; P Kirui; J Bwayo; M Temmerman Journal: Sex Transm Infect Date: 2000-02 Impact factor: 3.519
Authors: María del Mar Pujades Rodríguez; Angela Obasi; Frank Mosha; Jim Todd; David Brown; John Changalucha; David Mabey; David Ross; Heiner Grosskurth; Richard Hayes Journal: AIDS Date: 2002-02-15 Impact factor: 4.177
Authors: A Kamali; M Quigley; J Nakiyingi; J Kinsman; J Kengeya-Kayondo; R Gopal; A Ojwiya; P Hughes; L M Carpenter; J Whitworth Journal: Lancet Date: 2003-02-22 Impact factor: 79.321
Authors: Z Mike Chirenje; Nicholas Dhibi; H Hunter Handsfield; Elizabeth Gonese; Beth Tippett Barr; Lovemore Gwanzura; Ahmed S Latif; Dumisili Venessa Maseko; Ranmini S Kularatne; Mufuta Tshimanga; Peter H Kilmarx; Anna Machiha; Owen Mugurungi; Cornelis A Rietmeijer Journal: Sex Transm Dis Date: 2018-06 Impact factor: 2.830
Authors: Susan M Graham; Linnet Masese; Ruth Gitau; Barbra A Richardson; Kishor Mandaliya; Norbert Peshu; Walter Jaoko; Jeckoniah Ndinya-Achola; Julie Overbaugh; R Scott McClelland Journal: Sex Transm Infect Date: 2010-10-27 Impact factor: 3.519
Authors: S Aboud; G Msamanga; J S Read; A Mwatha; Y Q Chen; D Potter; M Valentine; U Sharma; I Hoffmann; T E Taha; R L Goldenberg; W W Fawzi Journal: Int J STD AIDS Date: 2008-12 Impact factor: 1.359
Authors: Susan M Graham; Linnet Masese; Ruth Gitau; Dickson Mwakangalu; Walter Jaoko; Jeckoniah Ndinya-Achola; Kishor Mandaliya; Norbert Peshu; Jared M Baeten; R Scott McClelland Journal: J Acquir Immune Defic Syndr Date: 2009-12 Impact factor: 3.731
Authors: Fredrick Odhiambo Otieno; Richard Ndivo; Simon Oswago; Johnson Ondiek; Sherri Pals; Eleanor McLellan-Lemal; Robert T Chen; Wairimu Chege; Kristen Mahle Gray Journal: Int J STD AIDS Date: 2014-02-10 Impact factor: 1.359
Authors: T R Suntoke; A Hardick; A A R Tobian; B Mpoza; O Laeyendecker; D Serwadda; P Opendi; C A Gaydos; R H Gray; M J Wawer; T C Quinn; S J Reynolds Journal: Sex Transm Infect Date: 2008-12-09 Impact factor: 3.519
Authors: Mark I Chen; Anna von Roenne; Yaya Souare; Franz von Roenne; Akaco Ekirapa; Natasha Howard; Matthias Borchert Journal: Confl Health Date: 2008-10-23 Impact factor: 2.723